2026 ICD-10-CM Diagnosis Code Z15.02Genetic susceptibility to malignant neoplasm of ovary
Z15.02 is a billable ICD-10-CM diagnosis code for genetic susceptibility to malignant neoplasm of ovary. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). The code is not accepted as a principal diagnosis by the Medicare Code Editor and exempt from POA reporting. Coders also document this condition as ovarian cancer genetic marker of susceptibility positive. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Genetic susceptibility to disease.
Code Identity
Code Classification
Code EditsBilling
Medicare Code Editor checks that affect claim validity for Z15.02.
Present on Admission (POA)Billing
Z15.02 is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Ovarian cancer genetic marker of susceptibility positive
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Genetic
- susceptibility to disease NEC - Z15.89
- ovary - Z15.02
- Susceptibility to disease, genetic - Z15.89
- ovary - Z15.02
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Genetic
- susceptibility to disease NEC
- malignant neoplasm
- ovary
- Susceptibility to disease, genetic
- malignant neoplasm
- ovary
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Convert Z15.02 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About Z15.02Overview
Is Z15.02 (Genetic susceptibility to malignant neoplasm) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report genetic susceptibility to malignant neoplasm of ovary on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
Can Z15.02 be a principal diagnosis?
No. The Medicare Code Editor rejects this code as a principal diagnosis because genetic susceptibility to malignant neoplasm of ovary describes a circumstance that influences health status rather than a current illness. Report it as a secondary diagnosis.
Is Z15.02 exempt from POA reporting?
Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for genetic susceptibility to malignant neoplasm of ovary on inpatient claims.
What is the ICD-9 equivalent of Z15.02?
Under the General Equivalence Mappings, genetic susceptibility to malignant neoplasm of ovary converts to ICD-9-CM V84.02 (genetc sus mal neo ovary). The mapping is a direct match.
